➤ What is the best Medicare Advantage plan for 2027?
There is no single best plan, because Medicare Advantage is sold county by county. On our 2027 scorecard, Humana ranks first at 84 points after its star ratings jumped to about 95% of members in 4-star-plus plans, followed by UnitedHealthcare at 80, Aetna at 75 and Kaiser Permanente at 73. If Kaiser sells in your county, start there, because it ranks fourth only on availability.
➤ What company has the highest rated Medicare Advantage plans for 2027?
Among large national carriers, Humana now has the highest share of members in 4-star-or-better plans for 2027, at about 95%. Kaiser Permanente had essentially 100% for 2026 but sells in only nine states plus DC and has not yet published its 2027 figure. CMS rates the contract rather than the carrier, so always check the rating on the specific plan in your county.
➤ Is Humana a good Medicare Advantage plan for 2027?
On quality, yes: about 95% of Humana’s members are in plans rated 4 stars or higher for 2027, up from about 20% for 2026, and its national PPO contract rose to 4 stars. It is also strong on price and Part B giveback availability. The caution is stability, since Humana is exiting 57 counties and Minnesota and cutting 37 PPO plans, so confirm your plan continues before you enroll.
➤ Is UnitedHealthcare or Humana better for 2027?
Humana now leads on star ratings, with about 95% of members in 4-star-plus plans against an analyst-estimated 67% for UnitedHealthcare. UnitedHealthcare leads on network size and county coverage, and it holds three of the 15 five-star contracts for 2027. Which is better depends on whether quality or network breadth matters more to you, and on which plans each sells in your county.
➤ Which Medicare Advantage carriers are cutting plans for 2027?
Humana is exiting 57 counties and Minnesota, UnitedHealthcare about 140 counties and Wyoming, Aetna 123 counties plus Maryland and New Hampshire, and Centene 344 counties plus Hawaii, Oklahoma and Tennessee. Elevance is pulling plans from 56 counties and exiting South Carolina, and Kaiser is leaving 5 counties. Molina and Presbyterian are moving to special needs plans only.
➤ What will happen to Medicare Advantage plans in 2027?
The market is contracting. Johns Hopkins research puts roughly 2.9 million members, about one in ten, in plans being discontinued. The average premium falls to $12.00 a month, but out-of-pocket limits and drug deductibles are rising, the Part D cap rises to $2,400, and only 15 contracts earned five stars for 2027, down from 22.
➤ How do I know if my Medicare Advantage plan is being discontinued?
Your plan must send an Annual Notice of Change by September 30, and a separate non-renewal notice if the plan is ending. If it is, you generally qualify for a Special Enrollment Period, and you may have a guaranteed-issue right to buy certain Medigap policies. The notice from your carrier is the document that matters.
➤ Do Medicare Advantage star ratings actually matter?
They are the only quality measure that is independently calculated and applied identically to every carrier. They lag, and they rate the contract rather than the plan, but no better standardized comparison exists. They also carry money: contracts at 4 stars or higher earn bonus payments that plans generally use to fund extra benefits.
➤ When did the 2027 Medicare Advantage star ratings come out?
CMS released the 2027 star ratings on October 8, 2026, a week after plan details went live on Medicare Plan Finder on October 1. Annual Enrollment runs October 15 through December 7, 2026, for coverage beginning January 1, 2027.
➤ Is Medicare Advantage worth it in 2027?
For most people who choose it, yes: 35.2 million Americans, or 55% of everyone eligible for Medicare, are in a Medicare Advantage plan. It typically costs less monthly and may bundle drug coverage and extras, in exchange for a provider network and prior authorization rules. If you live in a rural county where a carrier is leaving, price a Medigap policy alongside your options while you have guaranteed-issue rights.